Company: APXIF
Filing Date: 2025-03-31
Form Type: F-4/A
Source: 0001213900-25-026339
Chunk: 179

Company: APx Acquisition Corp. I
Filing Date: 2025-03-31
Form: F-4/A
Chunk 179
---
 our board of directors and will depend on our financial condition, operating results, capital requirements, general business conditions and other factors that our board of directors may deem relevant. As a result, capital appreciation, if any, of our ordinary shares will be the sole source of gain for the foreseeable future, and our ordinary shares may be less valuable if such price appreciation never occurs for shareholders to realize gains on their investment. If securities or industry analysts issue an adverse or misleading opinion regarding our shares or do not publish research or reports about our business, our share price and trading volume could decline. The trading market for our ordinary shares will depend in part on the research and reports that industry or securities analysts publish about us and our business. We do not control these analysts or the content and opinions included in their reports. Securities analysts may elect not to provide research coverage of our company and such lack of research coverage may adversely affect the market price of our ordinary shares. The price of our ordinary shares could also decline if one or more equity research analysts downgrade our ordinary shares, change their price targets, issue other unfavorable commentary or cease publishing reports about us or our business. If one or more of these analysts cease coverage of our company or fail to publish reports on us regularly, we could lose visibility in the market, which in turn could cause our share price and trading volume to decline. 70 Provisions in the Company M&A and under Cayman Islands law could discourage, delay or prevent a change in control of our company and may affect the trading price of our ordinary shares. Provisions in the Company M&A may have the effect of delaying or preventing a change of control or changes in our management. The Company M&A will include provisions that: •authorize our directors to allot, grant options over or otherwise deal with any unissued shares with or without preferred, deferred or other special rights or restrictions, without further action by the shareholders; •authorize our directors to appoint additional directors to office for such period and on such terms, including as to remuneration, as they think fit; •provide that vacancies on our board of directors may, except as otherwise required by law, be filled only by an ordinary resolution passed by a simple majority of shareholder members or by the directors; and •require a super -majorityof votes to amend certain of the above -mentionedprovisions as well as to amend our articles of association generally. Certain provisions of the Company M&A may make a change in control of us more difficult to effect. The Company M&A will provide for a staggered